On May 10, 2024, Palisade Bio, Inc. closed the transaction. The company issued 85,100 shares, par value $0.01 per share at a price of $6.5015 per share for gross proceeds of $553,277.65; and 530,142 prefunded warrants at a price of $6.5014 per warrant for gross proceeds of $3,446,665.1988, bringing proceeds to $3,999,942.8488. The company has paid $309,999 placement agent fees in the transaction.

The company has received $3,999,942 from single investor pursuant to exemption provided under Regulation D.